10-Q: Chicago Atlantic Real Estate Finance Q2 2026 Earnings Decline Amidst Merger Plans

Chicago Atlantic Real Estate Finance reported a decrease in net income and net interest income for Q2 2026, alongside a substantial rise in credit loss provisions, while progressing with its merger with Chicago Atlantic BDC, Inc.

Summary

• Chicago Atlantic Real Estate Finance, Inc. (REFI) reported a net income of $7.5 million for the three months ended June 30, 2026, a decrease from $8.9 million in the same period last year.
• Net interest income for the quarter was $12.8 million, down from $14.4 million in Q2 2025, primarily due to lower exit/success fees and a decrease in cash interest income.
• The provision for current expected credit losses significantly increased to $0.55 million in Q2 2026 from $1.15 million in Q2 2025, indicating higher anticipated loan defaults.
• Total expenses for the quarter were $5.1 million, a 10% decrease year-over-year, largely driven by lower management and incentive fees.
• The company is progressing with its proposed merger with Chicago Atlantic BDC, Inc. (LIEN), with the transaction expected to close in Q4 2026, subject to stockholder and regulatory approvals.
• As of June 30, 2026, total assets were $461.7 million, and total liabilities were $160.1 million, resulting in total stockholders' equity of $301.6 million.
• The company's loan portfolio consists of $412.1 million in principal outstanding, with a weighted average yield-to-maturity IRR of 15.6%.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as cautiously negative due to a decrease in net income and net interest income, coupled with a significant increase in the provision for expected credit losses, despite a proposed merger that offers potential future benefits.

Positives

• The company maintained a strong equity position with total stockholders' equity at $301.6 million as of June 30, 2026.
• Total expenses decreased by 10% year-over-year to $5.1 million for the quarter, primarily due to reduced management and incentive fees.
• The company has $19.0 million in borrowing capacity available under its Revolving Loan as of June 30, 2026.
• The proposed merger with Chicago Atlantic BDC, Inc. is progressing, with an expected closing in Q4 2026, which could lead to future strategic benefits.
• The company collected all past due interest on Loan #36 in April 2026 and amended the loan terms, keeping it on accrual status.
• The company has no material pending legal proceedings as of June 30, 2026.

Negatives

• Net income decreased by 16% to $7.5 million for the three months ended June 30, 2026, compared to $8.9 million in the prior year period.
• Net interest income decreased by 11% to $12.8 million for the quarter, driven by lower exit/success fees and cash interest income.
• The provision for current expected credit losses increased significantly by 52% to $0.55 million for the quarter, indicating increased credit risk.
• The weighted average yield-to-maturity IRR on the loan portfolio decreased from 16.8% at June 30, 2025, to 15.6% at June 30, 2026.
• The company's loan portfolio has a concentration risk, with the top three borrowers representing 31.5% of the principal outstanding as of June 30, 2026.
• The company's book value per share decreased to $14.15 as of June 30, 2026, from $14.60 as of December 31, 2025.

Risks

• The federal illegality of cannabis poses significant risks, including strict enforcement against borrowers, inability to renew licenses, and lack of loan liquidity.
• The proposed merger with Chicago Atlantic BDC, Inc. is subject to numerous closing conditions, and there is no assurance it will be completed on the anticipated terms or timing, or at all.
• Movement in the Exchange Ratio between signing and closing of the merger may result in REFI stockholders receiving fewer shares of LIEN common stock than currently anticipated.
• The company's election to be regulated as a business development company (BDC) in connection with the merger will fundamentally change its regulatory framework.
• The company's loan portfolio is concentrated, with the top three borrowers representing 31.5% of the principal outstanding as of June 30, 2026.
• Adverse changes in real estate values, interest rates, occupancy levels, or macroeconomic conditions could result in material increases in the company's allowance for credit losses.
• The rescheduling of cannabis by the DEA is subject to ongoing administrative review and uncertainty, potentially affecting borrower cash flows and introducing operational complexities.
• Increased competition in the cannabis lending market could result in compression of lending spreads and reduced origination opportunities.

Future Outlook

The company anticipates continued growth in its loan portfolio, driven by demand in the cannabis industry. However, it faces challenges related to increasing competition, regulatory uncertainties surrounding cannabis, and the ongoing proposed merger with Chicago Atlantic BDC, Inc. The merger is expected to close in Q4 2026, after which the company will operate as a BDC. The company believes its current cash on hand and borrowing capacity will be sufficient for the next twelve months.

Management Comments

• "Our primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, primarily through consistent current income (dividends and distributions) and secondarily, through capital appreciation."
• "We believe that cannabis operators limited access to traditional bank and non-bank financing has provided attractive opportunities for us to make loans to companies that exhibit strong fundamentals but require more customized financing structures and loan products than regulated financial institutions can provide in the current regulatory environment."
• "The rescheduling of qualifying medical cannabis activities may affect the financial and operating profile of the borrowers within our portfolio."
• "We believe that our cash on hand, capacity available under our Revolving Loan, and cash flows from operations for the next twelve months will be sufficient to satisfy the operating requirements of our business through at least the next twelve months."

Industry Context

StockSavvy.ai notes that the company operates in the specialized niche of financing for the cannabis industry, which is characterized by unique regulatory challenges and evolving market dynamics. The recent DEA order to reclassify certain cannabis products to Schedule III presents both opportunities for improved borrower cash flows (due to potential Section 280E relief) and complexities in implementation and enforcement. The proposed merger with a BDC signals a strategic shift, potentially broadening the company's investment scope and regulatory framework.

Comparison to Industry Standards

• The company's weighted average yield-to-maturity IRR of 15.6% as of June 30, 2026, is generally higher than traditional commercial real estate debt funds, reflecting the higher risk profile of the cannabis industry.
• The increase in the provision for current expected credit losses to 2.27% of principal on loans held for investment as of June 30, 2026, from 1.23% as of December 31, 2025, indicates a rising concern for credit quality within the portfolio, which may be higher than industry averages for less specialized lending sectors.
• The company's loan-to-enterprise value ratio of 46.0% as of June 30, 2026, suggests a moderate level of leverage relative to borrower enterprise value, which is a key metric for assessing risk in this sector.
• The company's focus on senior secured loans to state-licensed cannabis operators aligns with common strategies in this niche, aiming to mitigate risk through collateral and licensing requirements, though the federal illegality remains a significant differentiator from standard CRE lending.

Legal Proceedings

• The company is not aware of any legal claims that could materially impact its business, financial condition, or results of operations as of June 30, 2026.

Related Party Transactions

• The company originated a $41.0 million second-lien secured term loan to a related party (Loan #51) on June 1, 2026.
• The company completed a non-cash exchange of loans with Chicago Atlantic Credit Opportunities, LLC (CACO), an affiliated private investment fund, on June 1, 2026.
• Loan #9 (Hive Holdings, Inc.) is considered a related party loan due to affiliated co-lender involvement.
• Loan #18 (FarmaceuticalRX, LLC) is considered a related party due to common control affiliates exercising significant influence.
• Loan #48 (FarmaceuticalRX, LLC) is considered a related party due to convertible features in affiliate investments providing controlling interest.
• Loan #50 (Intrinsic Manufacturing & Processing, LLC) is considered a related party transaction due to co-investment by affiliates and common control.
• The company's Manager agreed to bear up to $2.0 million of the company's share of merger transaction expenses.

Stakeholder Impact

• Shareholders: The decrease in net income and book value per share may negatively impact shareholder sentiment. However, the proposed merger could offer future strategic benefits and potential value appreciation.
• Creditors: The company's leverage ratios and debt covenants are being monitored. The company is in compliance with its debt covenants as of June 30, 2026.
• Employees: The merger with LIEN and the potential change in regulatory framework (from REIT to BDC) could lead to organizational changes and integration challenges.
• Borrowers: The company's increased provision for credit losses and focus on de-risking the portfolio may lead to stricter lending terms or reduced availability of credit for certain borrowers, particularly those in higher-risk segments of the cannabis industry.

Next Steps

• Complete the proposed merger with Chicago Atlantic BDC, Inc., expected in Q4 2026.
• Obtain necessary stockholder and regulatory approvals for the merger.
• Implement the BDC regulatory framework following the merger.
• Continue to monitor and manage the loan portfolio, including credit quality and risk assessments.
• Potentially resume ATM program sales once the new shelf registration statement is effective and merger restrictions are addressed.

Key Dates

Recommendation

The company's financial performance has weakened with declining net income and interest income, coupled with an increased provision for credit losses. However, the proposed merger with LIEN and the strategic shift to a BDC structure present potential future upside. The current environment warrants a 'hold' rating to observe the successful completion of the merger and its subsequent impact on financial performance and strategic direction.

Keywords

Real Estate Finance, Cannabis Lending, Commercial Real Estate, Mortgage Loans, REIT, Credit Risk, Merger, CECL